期刊
NEOPLASIA
卷 15, 期 6, 页码 641-+出版社
NEOPLASIA PRESS
DOI: 10.1593/neo.121866
关键词
-
类别
资金
- INSERM
- Institut du Cancer [INCA 2005]
- Canceropole-Ile de France
- Agence Nationale de la Recherche Cardiovasculaire, Obesite et Diabete [AO5088DS]
- ANR blanc [AO5120DD]
- European grant Innochem [LSHB-CT-2005-518167]
- European grant Innochem [518167]
- Neuropole de Recherche Francilien
- Interface from Assistance Publiques-Hopitaux de Paris
Expression of the CC chemokine receptor 1 (CCR1) by tumor cells has been associated with protumoral activity; however, its role in nontumoral cells during tumor development remains elusive. Here, we investigated the role of CCR1 deletion on stromal and hematopoietic cells in a liver metastasis tumor model. Metastasis development was strongly impaired in CCR1-deficient mice compared to control mice and was associated with reduced liver monocyte infiltration. To decipher the role of myeloid cells, sublethally irradiated mice were reconstituted with CCR1-deficient bone marrow (BM) and showed better survival rates than the control reconstituted mice. These results point toward the involvement of CCR1 myeloid cell infiltration in the promotion of tumor burden. In addition, survival rates were extended in CCR1-deficient mice receiving either control or CCR1-deficient BM, indicating that host CCR1 expression on nonhematopoietic cells also supports tumor growth. Finally, we found defective tumor-induced neoangiogenesis (in vitro and in vivo) in CCR1-deficient mice. Overall, our results indicate that CCR1 expression by both hematopoietic and nonhematopoietic cells favors tumor aggressiveness. We propose CCR1 as a potential therapeutical target for liver metastasis therapy.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据